Capricor Therapeutics CAPR Insider Ownership

NASDAQ CAPR

$5.88 -0.73 (-11.04%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

7.70Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

1.02%

▼-12.20% pp QoQ

Shares Held by Insiders

591.53K

filed for Sep 2026

▼-92.30% QoQ

Shares Outstanding

58.11Mn

58,108,989 shares

Direct Holdings

545.25K

Indirect: 46.28K

Net Shares Traded (QoQ)

-7.09Mn

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 11, 2026

Across the past 12 months, open-market trades by Capricor Therapeutics insiders were all sales, totaling $7.61 million (247.53K shares).

Behind Capricor Therapeutics' open-market sales in the past 12 months were 3 insiders, and no insider bought.
Karimah Es Sabar (Director) was CAPR's largest open-market seller in the past 12 months, with $3.76 million of sales (122.53K shares); the latest was on April 2, 2026.
The latest open-market trade on record is a sale of 24.1K shares for $732,158 by Karen Krasney (EVP, General Counsel) on June 25, 2026.
Away from the open market, CAPR insiders acquired 232.47K shares through option exercises and conversions over the last 12 months.
Per Business Quant data, Capricor Therapeutics insiders hold 591.53K shares in total based on their latest Form 4 filings.
By type of ownership, CAPR insiders hold 92.18% of their shares directly (545.25K shares) and 7.82% indirectly (46.28K shares).
Per Business Quant, 8 insiders of CAPR hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
CAPR's three largest insider shareholders, per their latest Form 4 filings, are Linda Marban (Chief Executive Officer, 211.1K shares), Frank Litvack (Director, 180.05K shares) and David B. Musket (Director, 81.69K shares).
Of the shares held by CAPR insiders, 35.69% belong to Linda Marban.
Institutional investors held 66.90% of Capricor Therapeutics stock at the end of Q2 2026, while the latest Form 4 filings of its insiders account for about 1.02%; other investors, including the public, hold roughly 32.08%.
In the past year, 11 insiders of Capricor Therapeutics submitted 24 Form 4 filings reporting trades, awards or other transactions.
The insider holdings and trades above for Capricor Therapeutics reflect Form 4 filings through June 29, 2026.

Form 4 Holdings

Insiders Holding CAPR

Insiders 10

Shares held 7.70Mn

Of outstanding 13.25%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Shinyaku Co Ltd Nippon	TenPercentOwner	7,090,351	7,090,351	92.1%	24 Sep, 2024
2	Linda Marban	Chief Executive Officer	211,104	211,104	2.7%	05 Mar, 2025
3	Frank Litvack	Director	133,776	133,776	1.7%	14 May, 2026
4	David B Musket	Director	81,692	81,692	1.1%	09 Aug, 2024
5	Louis Manzo	Director	62,147	62,147	0.8%	23 Feb, 2023
6	Earl M Jr Collier	Director	57,606	57,606	0.7%	28 Feb, 2025
7	Karen Krasney	Evp, General Counsel	30,547	30,547	0.4%	29 Jun, 2026
8	George W Jr Dunbar	Director	14,306	14,306	0.2%	23 Dec, 2025
9	Anthony Bergmann	Chief Financial Officer	11,223	11,223	0.1%	29 Jun, 2026
10	Paul Gisbert Auwaerter	Director	5,000	5,000	0.1%	10 Oct, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

596 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
25 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Acquired M	24,100	$3.18	$76.64K	35,323	Direct
25 Jun, 2026	Karen Krasney	Evp, General Counsel	Acquired M	24,100	$3.18	$76.64K	54,647	Direct
25 Jun, 2026	Karen Krasney	Evp, General Counsel	Disposed S	24,100	$30.38	$732.16K	30,547	Direct
25 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Disposed S	24,100	$30.38	$732.16K	11,223	Direct
25 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Disposed M	24,100	$0.00	$0	91,980	Direct
25 Jun, 2026	Karen Krasney	Evp, General Counsel	Disposed M	24,100	$0.00	$0	31,261	Direct
22 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Acquired M	500	$3.18	$1.59K	11,723	Direct
22 Jun, 2026	Karen Krasney	Evp, General Counsel	Acquired M	500	$3.18	$1.59K	31,047	Direct
22 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Disposed S	500	$30.00	$15.00K	11,223	Direct
22 Jun, 2026	Karen Krasney	Evp, General Counsel	Disposed S	500	$30.00	$15.00K	30,547	Direct
24 Jun, 2026	Karen Krasney	Evp, General Counsel	Acquired M	400	$3.18	$1.27K	30,947	Direct
24 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Acquired M	400	$3.18	$1.27K	11,623	Direct
24 Jun, 2026	Karen Krasney	Evp, General Counsel	Disposed S	400	$30.00	$12.00K	30,547	Direct
24 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Disposed S	400	$30.00	$12.00K	11,223	Direct
22 Jun, 2026	Karen Krasney	Evp, General Counsel	Disposed M	500	$0.00	$0	55,761	Direct
22 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Disposed M	500	$0.00	$0	116,480	Direct
24 Jun, 2026	Karen Krasney	Evp, General Counsel	Disposed M	400	$0.00	$0	55,361	Direct
24 Jun, 2026	Anthony Bergmann	Chief Financial Officer	Disposed M	400	$0.00	$0	116,080	Direct
26 May, 2026	Michael T Maurer	Chief Commercial Officer	Acquired A	80,000	$0.00	$0	80,000	Direct
18 May, 2026	Anthony Bergmann	Chief Financial Officer	Acquired M	3,000	$1.39	$4.17K	11,223	Direct

Showing 1 to 20 of 596 transactions